| NCT ID | NCT07145567 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Microangiopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-03-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.
Eligibility Criteria
Inclusion Criteria: * Diabetes mellitus type 1. * Cohort specific inclusion criteria apply, please review 'groups' section. Exclusion Criteria: * Patients unable to understand patient information due to cognitive impairment. * Patients unable to understand patient information due to language barriers. * Ongoing acute infection disease or inflammatory condition. * Pregnant or breast-feeding women. * Patients with damaged and/or scarred tissue in the areas of interest for the investigational or comparator devices.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07145567 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Microangiopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07145567 currently recruiting?
Yes, NCT07145567 is actively recruiting participants. Contact the research team at sara.tehrani@ki.se for enrollment information.
Where is the NCT07145567 trial being conducted?
This trial is being conducted at Danderyd, Sweden.
Who is sponsoring the NCT07145567 clinical trial?
NCT07145567 is sponsored by Karolinska Institutet. The trial plans to enroll 400 participants.